Zhiyong Yu

Academic / Other · 7 registered clinical trials.

Status	Trial	Phase	Started
Unknown	Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients Wi Metastatic Breast Cancer	Phase 2	2021-08-01
Unknown	RWS of Inetetamab HER2 Positive Advanced Breast Cancer HER2-positive Advanced Breast Cancer	—	2021-07-01
Unknown	Capecitabine Versus Vinorelbine in High Risk Breast Cancer With Pathologic Residual Tumors After Preoperative Pathologic Residual Cancer Cells	Phase 2	2018-11-01
Unknown	Potential of Circulating Tumor DNA to Assess the Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer P Breast Cancer, Neoadjuvant Chemotherapy, Circulating Tumor DNA	—	2018-09-20
Unknown	The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Ther Breast Cancer, Chemotherapy Effect, Disease-free Survival	Phase 2 / Phase 3	2018-02-08
Unknown	Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Ca Breast Cancer, Chemotherapy, Endocrine Breast Diseases	Phase 2 / Phase 3	2017-12-20
Unknown	Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Che Breast Cancer, Pathological Complete Response, Neoadjuvant Chemotherapy	Phase 2 / Phase 3	2017-11-27